Bashan Dror - Insider Non-Derivative Transactions at Protalix BioTherapeutics, Inc. (PLX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 19, 2025, Bashan Dror's relationship to Protalix BioTherapeutics, Inc. (PLX) is Director,Officer (PRESIDENT AND CEO), and currently has 188,516 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PLX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Bashan Dror - Insider Non-Derivative Transactions of PLX Common Stock

Bashan Dror - Insider Non-Derivative Transactions at PLX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 20, 2025	P -- (Common Stock)	56000	1.81	188516
Sep 4, 2025	Acquisition -- (Common Stock)	195000	0	2344418
Apr 2, 2024	Acquisition -- (Common Stock)	263960	0	2149418
Oct 20, 2023	P -- (Common Stock)	48387	1.4	116387
Oct 20, 2023	P -- (Common Stock)	16129	1.41	132516
Aug 16, 2023	Acquisition -- (Common Stock)	800000	0	1885458